Ardelyx, Inc. (ARDX)
3.09
-0.18
(-5.50%)
USD |
NASDAQ |
Oct 16, 16:00
3.11
+0.02
(+0.65%)
After-Hours: 20:00
Ardelyx Net Income (TTM) : -55.70M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.70M |
| March 31, 2026 | -58.06M |
| December 31, 2025 | -61.60M |
| September 30, 2025 | -56.55M |
| June 30, 2025 | -56.39M |
| March 31, 2025 | -53.76M |
| December 31, 2024 | -39.14M |
| September 30, 2024 | -72.58M |
| June 30, 2024 | -65.14M |
| March 31, 2024 | -65.81M |
| December 31, 2023 | -66.07M |
| September 30, 2023 | -26.57M |
| June 30, 2023 | -56.09M |
| March 31, 2023 | -65.91M |
| December 31, 2022 | -67.21M |
| September 30, 2022 | -114.14M |
| June 30, 2022 | -134.83M |
| March 31, 2022 | -153.08M |
| December 31, 2021 | -158.16M |
| September 30, 2021 | -150.81M |
| June 30, 2021 | -125.33M |
| March 31, 2021 | -105.10M |
| December 31, 2020 | -94.31M |
| September 30, 2020 | -85.23M |
| Date | Value |
|---|---|
| June 30, 2020 | -90.66M |
| March 31, 2020 | -91.17M |
| December 31, 2019 | -94.94M |
| September 30, 2019 | -103.01M |
| June 30, 2019 | -103.60M |
| March 31, 2019 | -100.42M |
| December 31, 2018 | -91.30M |
| September 30, 2018 | -53.32M |
| June 30, 2018 | -49.92M |
| March 31, 2018 | -53.35M |
| December 31, 2017 | -64.34M |
| September 30, 2017 | -105.73M |
| June 30, 2017 | -114.04M |
| March 31, 2017 | -116.93M |
| December 31, 2016 | -112.39M |
| September 30, 2016 | -98.11M |
| June 30, 2016 | -87.21M |
| March 31, 2016 | -49.59M |
| December 31, 2015 | -29.62M |
| September 30, 2015 | -16.59M |
| June 30, 2015 | 1.609M |
| March 31, 2015 | -5.784M |
| December 31, 2014 | -3.214M |
| September 30, 2014 | 0.286M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Capricor Therapeutics, Inc. | -129.42M |
| REGENXBIO, Inc. | -196.43M |
| Compass Therapeutics, Inc. | -73.45M |
| ARS Pharmaceuticals, Inc. | -215.43M |
| Sionna Therapeutics, Inc. | -97.38M |